Skip Navigation
Skip to contents

KMJ : Kosin Medical Journal


Author index

Page Path
HOME > Browse articles > Author index
Suk Bong Koh 2 Articles
The ideal strategies of chemotherapy for the treatment of cervical cancer
Suk Bong Koh
Kosin Med J. 2018;33(3):283-288.   Published online December 31, 2018
  • 298 View
  • 3 Download
Abstract PDFPubReader   CrossRef-TDMCrossref - TDM

Historically, the standard treatment for early-stage cervical cancer has been radical surgery in patients with operable disease. Patients with locally advanced disease (defined as FIGO stage IB2 and usually with tumors greater than 4 cm, IIB, III and IVA) are usually treated with radical radiotherapy, which consists of external beam radiotherapy and internal brachytherapy. However, the discovery that cervical cancer tumors are sensitive to chemotherapy led to the initiation of studies looking at adding chemotherapy to both radiotherapy and surgery. Following a National Cancer Institute (NCI) alert in 1999 (NCI 1999), chemoradiotherapy became the standard of care for women with locally advanced cervical cancer.1

Current Medical Therapy for Uterine Leiomyomas
Suk Bong Koh
Kosin Med J. 2017;32(1):17-24.   Published online June 30, 2017
  • 273 View
  • 2 Download
Abstract PDFPubReader   ePub   CrossRef-TDMCrossref - TDM

Uterine leiomyomas are benign tumors arising from the myometrium and largely prevalent in the woman's reproductive years. The majority of women with leiomyomas either remain asymptomatic or develop symptoms gradually over time. When patients are symptomatic, the nature of their complaints is often attributable to the number, size, and/or location of their fibroids. Depending on a patient's symptomatology and reproductive plans, treatment options include expectant management, medical management (hormonal and non-hormonal), or surgical management (myomectomy or hysterectomy).

KMJ : Kosin Medical Journal